These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31774708)

  • 21. Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934.
    Ashley DM; Merchant TE; Strother D; Zhou T; Duffner P; Burger PC; Miller DC; Lyon N; Bonner MJ; Msall M; Buxton A; Geyer R; Kun LE; Coleman L; Pollack IF
    J Clin Oncol; 2012 Sep; 30(26):3181-6. PubMed ID: 22851568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subgroup and subtype-specific outcomes in adult medulloblastoma.
    Coltin H; Sundaresan L; Smith KS; Skowron P; Massimi L; Eberhart CG; Schreck KC; Gupta N; Weiss WA; Tirapelli D; Carlotti C; Li KKW; Ryzhova M; Golanov A; Zheludkova O; Absalyamova O; Okonechnikov K; Stichel D; von Deimling A; Giannini C; Raskin S; Van Meir EG; Chan JA; Fults D; Chambless LB; Kim SK; Vasiljevic A; Faure-Conter C; Vibhakar R; Jung S; Leary S; Mora J; McLendon RE; Pollack IF; Hauser P; Grajkowska WA; Rubin JB; van Veelen MC; French PJ; Kros JM; Liau LM; Pfister SM; Kool M; Kijima N; Taylor MD; Packer RJ; Northcott PA; Korshunov A; Ramaswamy V
    Acta Neuropathol; 2021 Nov; 142(5):859-871. PubMed ID: 34409497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen.
    Baroni LV; Sampor C; Gonzalez A; Lubieniecki F; Lamas G; Rugilo C; Bartels U; Heled A; Smith KS; Northcott PA; Bouffet E; Alderete D; Ramaswamy V
    Neuro Oncol; 2020 Dec; 22(12):1873-1881. PubMed ID: 32413139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature.
    Siegfried A; Bertozzi AI; Bourdeaut F; Sevely A; Loukh N; Grison C; Miquel C; Lafon D; Sevenet N; Pietsch T; Dufour C; Delisle MB
    Clin Neuropathol; 2016; 35(3):106-13. PubMed ID: 26857864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
    Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
    Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
    Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
    Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
    Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
    Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.
    Dhall G; O'Neil SH; Ji L; Haley K; Whitaker AM; Nelson MD; Gilles F; Gardner SL; Allen JC; Cornelius AS; Pradhan K; Garvin JH; Olshefski RS; Hukin J; Comito M; Goldman S; Atlas MP; Walter AW; Sands S; Sposto R; Finlay JL
    Neuro Oncol; 2020 Dec; 22(12):1862-1872. PubMed ID: 32304218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High-dose chemotherapy in relapse of medulloblastoma in young children].
    Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
    Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).
    Moots PL; O'Neill A; Londer H; Mehta M; Blumenthal DT; Barger GR; Grunnet ML; Grossman S; Gilbert MR; Schiff D
    Am J Clin Oncol; 2018 Jun; 41(6):588-594. PubMed ID: 27635620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5.
    Dufour C; Foulon S; Geoffray A; Masliah-Planchon J; Figarella-Branger D; Bernier-Chastagner V; Padovani L; Guerrini-Rousseau L; Faure-Conter C; Icher C; Bertozzi AI; Leblond P; Akbaraly T; Bourdeaut F; André N; Chappé C; Schneider P; De Carli E; Chastagner P; Berger C; Lejeune J; Soler C; Entz-Werlé N; Delisle MB
    Neuro Oncol; 2021 Jul; 23(7):1163-1172. PubMed ID: 33377141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmoplastic nodular medulloblastoma in young children: a management dilemma.
    AbdelBaki MS; Boué DR; Finlay JL; Kieran MW
    Neuro Oncol; 2018 Jul; 20(8):1026-1033. PubMed ID: 29156007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
    Rutkowski S; Bode U; Deinlein F; Ottensmeier H; Warmuth-Metz M; Soerensen N; Graf N; Emser A; Pietsch T; Wolff JE; Kortmann RD; Kuehl J
    N Engl J Med; 2005 Mar; 352(10):978-86. PubMed ID: 15758008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
    Franceschi E; Minichillo S; Mura A; Tosoni A; Mascarin M; Tomasello C; Bartolini S; Brandes AA
    BMC Cancer; 2020 Aug; 20(1):755. PubMed ID: 32787805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort.
    Kloth K; Obrecht D; Sturm D; Pietsch T; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S
    Front Oncol; 2021; 11():756025. PubMed ID: 34888241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.